The following contribution to our gene patenting symposium comes from Robert Merges, Wilson Sonsini Professor of Law, UC Berkeley and Visiting Professor of Law, Stanford Law School. Introduction And so it came to pass that the Supreme Court finally, after many years, took up the question of patents on human genes. Many of us in …
Posted Wed, February 6th, 2013 10:38 am by Robert Cook-Deegan The following contribution to our gene patenting symposium comes from Robert Cook-Deegan, Research Professor, Institute for Genome Sciences & Policy and Sanford School of Public Policy, Duke University. Association for Molecular Pathology v. Myriad Genetics is not your usual patent lawsuit. I come to it …
Questions that will remain unanswered from the Myriad case Read More »
Posted Tue, February 5th, 2013 10:43 am by Charles Rothfeld The following contribution to our gene patenting symposium comes from Charles Rothfeld, Special Counsel at Mayer Brown in Washington, DC. The question in Association for Molecular Pathology v. Myriad Genetics may strike a patent lawyer very differently than it does the generalist. The majority on …
The following contribution to our gene patenting symposium comes from Dan L. Burk, Chancellor’s Professor and founding faculty member at the University of California, Irvine School of Law. In April the Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics on the single question, “Are human genes patentable?” At issue in …
The following contribution to our gene patenting symposium comes from Arti K. Rai, Elvin R. Latty Professor of Law, Duke Law School and Duke Institute for Genome Sciences & Policy. From 2009-2010, Rai served as the USPTO Administrator for Policy and External Affairs. In three of the past four Terms, the Supreme Court has taken …
Patentable subject matter at the Supreme Court: An exceptional case? Read More »
